Based on this approval, CryoCor intends to begin selling its cryoablation system in the United States over the next several months. The Company will place an initial focus on console placement in high-volume ablation centers in the U.S. and is currently evaluating its sales and marketing requirements for this strategy. The Company has targeted an initial installed base of approximately 120 to 160 consoles by December 31, 2008, growing to approximately 300 consoles by 2010.
CONSOLE AND ARTICULATING CRYOARM™
The mobile Model 2020 Console is the control cente
r of the CryoCor™ Cardiac Cryoablation System. The console houses the control electronics, software and refrigeration components. With the Cryoablation Console, the user can initiate and control the cryo-ablation procedure using a few simple commands. A LCD screen displays command prompts and provides the operator with continual updates on system performance. The system uses a precooler located at the end of the articulating arm mounted to the console as part of a two-stage cooling process to optimize system efficiency and performance.
CryoCor Receives FDA Approval For Right Atrial Flutter
0 comments :
Post a Comment